Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
Chemotherapy-induced cardiomyopathy is a little known but serious side effect for cancer patients undergoing any type of cardiotoxic chemotherapy regimens.
I was diagnosed with multiple myeloma in early 1994. I underwent the FDA standard-of-care therapy plan which included several cardiotoxic therapies including:
I was diagnosed with chemotherapy-induced cardiomyopathy in late 2021 fully 15 years after my active cancer therapies. Both cardiologists I met with prescribed metoprolol. Neither mentioned anything about
I developed difficulties with this drug in the days that followed and decided to research and build into my lifestyle as many evidence-based, non-conventional heart health therapies as I could.
Several studies have explored the relationship between selenium levels and heart health:
The recommended dietary allowance (RDA) for selenium varies by age, sex, and life stage, but for most adults, it is around 55 micrograms per day. Selenium can be obtained from dietary sources such as:
Annal echocardiograms tell me that I have managed to stabilize and even improve many of the heart metrics that measure my heart health. I am not saying that my chemotherapy-induced cardiomyopathy is no longer a worry, much less cured.
What I am saying is that there are other ways to manage chemotherapy-induced cardiomyopathy than with conventional heart medications. Medications which often come with a long list of side effects.
I am not any sort of medical professional. I research and write about my experiences. I do not mean to apply any of this information and experience to my fellow cancer survivors who have chemotherapy-induced cardiomyopathy .
Are you a cancer patient undergoing cardiotoxic therapies? To learn more about both conventional and non-conventional therapies to reduce your risk of chemotherapy-induced cardiomyopathy, email me at David.PeopleBeatingCancer@gmail.com
thank you,
Conclusions-In summary, there exists an impressive body of evidence about the several important functions of selenium and its selenoproteins in the cardiovascular system, which are mainly due to its well-known antioxidant characteristics. Although the role of selenium supplementation in the prevention of cardiovascular diseases is inconclusive, it is important to clarify if selenium deficiency leads to new health implications, particularly in relation to acute cardiovascular disease, where patients are exposed to myocardial I/R and increased oxidative stress.”
“Selenium, a dietary trace mineral, essential for humans and animals, exerts its effects mainly through its incorporation into selenoproteins. Adequate selenium intake is needed to maximize the activity of selenoproteins, among which glutathione peroxidases have been shown to play a major role in cellular defense against oxidative stress initiated by excess reactive oxygen species.
In humans, a low selenium status has been linked to increased risk of various diseases, including heart disease.
The main objective of this review is to present current knowledge on the role of selenium in cardiac health. Experimental studies have shown that selenium may exert protective effects on cardiac tissue in animal models involving oxidative stress.
Because of the narrow safety margin of this mineral, most interventional studies in humans have reported inconsistent findings. Major determinants of selenium status in humans are not well understood and several nondietary factors might be associated with reduced selenium status. In this review, we discuss recent studies regarding the role of selenoproteins in the cardiovascular system, the effect of dietary intake on selenium status, the impact of selenium status on cardiac health, and the cellular mechanisms that can be involved in the physiological and toxic effects of selenium.”